The kinetics and magnitude of cytokine gene expression are tightly regulated to elicit a balanced response to pathogens and result from integrated changes in transcription and mRNA stability. Yet, how a single microbial stimulus induces peak transcription of some genes (TNF␣) within minutes whereas others (IP-10) require hours remains unclear. Here, we dissect activation of several lipopolysaccharide (LPS)-inducible genes in macrophages, an essential cell type mediating inflammatory response in mammals. We show that a key difference between the genes is the step of the transcription cycle at which they are regulated. Specifically, at TNF␣, RNA Polymerase II initiates transcription in resting macrophages, but stalls near the promoter until LPS triggers rapid and transient release of the negative elongation factor (NELF) complex and productive elongation. In contrast, no NELF or polymerase is detectible near the IP-10 promoter before induction, and LPS-dependent polymerase recruitment is rate limiting for transcription. We further demonstrate that this strategy is shared by other immune mediators and is independent of the inducer and signaling pathway responsible for gene activation. Finally, as a striking example of evolutionary conservation, the Drosophila homolog of the TNF␣ gene, eiger, displayed all of the hallmarks of NELF-dependent polymerase stalling. We propose that polymerase stalling ensures the coordinated, timely activation the inflammatory gene expression program from Drosophila to mammals. cytokine gene expression ͉ inflammation ͉ TNF␣ ͉ transcription initiation and elongation ͉ NELF
cytokine gene expression ͉ inflammation ͉ TNF␣ ͉ transcription initiation and elongation ͉ NELF I nnate immune responses are ancient programs that evolved to provide protection against invading pathogens. In addition to mobilizing professional phagocytic cells, e.g., macrophages (M⌽) and neutrophils, which actively prevent the dissemination of a given microbial agent and create a hostile extracellular environment for its replication, the innate immune system in higher organisms triggers much slower-acting adaptive immunity to mount a response should the primary defenses fail to contain the infection.
In recent years our understanding of the key molecular mechanisms underlying innate responses in mammals has greatly advanced. Host cells sense the presence of pathogens through a family of receptors, such as Toll-like receptors (TLRs), which detect conserved microbial components including lipopolysaccharide (LPS), peptidoglycans, single-stranded (ss) and double-stranded (ds) DNA and RNA, and common bacterial surface proteins, collectively known as pathogen-associated molecular patterns (PAMPs) (1, 2) . Upon activation, TLRs initiate a signaling cascade through adaptors and protein kinases that converge on transcriptional regulators nuclear factor (NF)B, activator protein (AP)1, and interferon (IFN) regulatory factors (IRFs) that, in turn, induce transcription of diverse proinflammatory cytokines and chemokines (3). These will ultimately activate M⌽ and dendritic cells and stimulate their migration to the site of invasion.
Because the innate response is rapid and relatively nonspecific, it imposes an intrinsic threat to the host if not properly contained.
Indeed, uncontrolled production of proinflammatory cytokines, e.g., tumor necrosis factor (TNF)␣, IL-1␤, and IFNs, is the underlying cause of the toxic shock syndrome. Persistent inflammation is also a hallmark of most autoimmune diseases: TNF␣ has been causally linked to joint destruction in rheumatoid arthritis, whereas pathogenesis of systemic lupus has been associated with dysregulated production of type I IFN (4) (5) (6) (7) .
Not surprisingly, numerous mechanisms have evolved to limit the levels of proinflammatory cytokines. In fact, many of them directly trigger negative feedback loops, including synthesis of antiinflammatory cytokines such as . Certain cytokine and chemokine proteins are synthesized as proforms (IL-1␤) or membranebound precursors (TNF␣), requiring proteolysis for activation (9, 10) . Secreted IL-1␤ can be sequestered by a decoy receptor (IL-1RII) or a soluble receptor antagonist (IL-1Ra), precluding it from signaling (10) . mRNAs encoding many proinflammatory mediators are intrinsically unstable because of the AU-rich elements (AREs) that bind proteins like tristetraprolin (TTP), which target the transcripts for mRNA decay (11) ; TNF␣, IL-6, IL-1␤, and IL-10 are all thought to be subject to TTP-mediated degradation (12, 13) . In fact, recent genomewide analysis described functionally distinct classes of proinflammatory molecules on the basis of their mRNA stability (14) .
Finally, proinflammatory gene transcription is one of the most sophisticated and tightly controlled gene expression programs. Indeed, DNA sequences associated with these genes are rich in binding sites for numerous transcriptional regulators, and the roles of AP1, NFB/Rel, and IRF families in cytokine gene expression have been studied extensively long before these factors were identified as the effectors of TLR signaling. A transcriptional response of a given cytokine gene may be capped by a sequential recruitment of different regulator family members to the element. For example, upon sustained exposure of M⌽ to LPS, cRel/p50 and p65/p50 heterodimers at the TNF␣ and CXCL2 genes are replaced by p50 homodimers, which correlates with cessation of transcription and LPS tolerance (15, 16) . Similarly, cofactor switch because of a signaling event, leading to modification of either the cofactor itself or the DNA-bound regulator responsible for its recruitment, can alter the rate of transcription or even reverse its polarity. For instance, cJun homodimers occupying the AP1 site of several proinflammatory genes in resting M⌽ mediate binding of the corepressor NCoR, which imposes a silent transcriptional state; exposure to LPS leads to cJun phosphorylation, heterodimerization with cFos, NCoR dismissal, and derepression (17) . Recently, nucleosome positioning was proposed to confer a particular transcriptional profile to genes with common chromatin structure (18) . On the basis of the differential requirements for Brg1/BRM and Mi-2b chromatin remodeling complexes, the authors described 3 types of genes encoding proinflammatory mediators that shared specific induction profiles under conditions tested (18) .
Although the studies above explain expression patterns of individual molecules, coordinate and sharp waves of expression of large sets of proinflammatory genes in response to a common stimulus imply that a broader regulatory mechanism may be in place. Notably, events in the transcription cycle subsequent to sequencespecific factor binding, cofactor recruitment, chromatin remodeling, and preinitiation complex (PIC) assembly may represent important points of regulation. In fact, recent work in Drosophila and human cells estimates that Ϸ20% of genes are regulated after RNA Polymerase (Pol) II recruitment to the gene promoter, by controlling the efficiency of early transcription elongation through the promoter-proximal region (19) (20) (21) . Importantly, this strategy for gene regulation was found to be enriched at stimulus-responsive genes in Drosophila (19, 22) . How widespread this regulatory checkpoint is in the mammalian innate immune system is unknown.
To understand the patterns of transcriptional responses to TLR signaling in M⌽, we examined transcription complex assembly at TNF␣, the prototypic proinflammatory cytokine, and several other mediators of inflammation. Our data indicate that these genes fall into distinct classes, depending on whether their transcription is controlled at the level of PIC recruitment vs. during transcription elongation, and that their induction profile correlates with the rate-limiting step in a transcription cycle rather than signaling events leading to their activation.
Results

RNA Polymerase II Occupies the TNF␣ Proximal Promoter in M⌽ Before
Gene Activation. TNF␣ gene expression is strongly induced in response to microbial products: LPS treatment of the murine RAW264.7 M⌽-like cell line and of primary bone marrow-derived M⌽ (BMM⌽) led to a dramatic increase in TNF␣ transcript ( Fig. 1 A and B, Left) . Unexpectedly, chromatin immunoprecipitation (ChIP) analysis revealed a significant RNA Pol II occupancy near the TNF␣ promoter under basal conditions in both cell contexts ( Fig. 1 A and B, Right) . This high ''basal'' Pol II occupancy was focused in the promoter-proximal region; far less Pol II was detected upstream or farther downstream of the transcription start site (TSS). LPS treatment triggered a significant increase in Pol II signal particularly within the downstream region of TNF␣, suggesting that LPS-mediated gene activation facilitates the release of Pol II from the promoter into the gene. This Pol II binding pattern resembled that described for genes whose promoters are regulated at a step subsequent to Pol II recruitment and are constitutively occupied by ''stalled'' or ''paused'' Pol II. Pol II stalling, increasingly appreciated as a widespread regulatory checkpoint in transcription (19) (20) (21) , occurs when Pol II initiates and produces a short RNA transcript but stalls during elongation through the promoter-proximal region.
LPS Target Genes in BMM⌽ Display Different Patterns of Pol II
Occupancy and Phosphorylation. The C-terminal domain (CTD) of the Pol II largest subunit contains a series of heptapeptide repeats (YS 2 PTS 5 PS) that can be differentially phosphorylated during the transcription cycle. Interestingly, the stalled Poll II displays a characteristic phosphorylation pattern, whereby levels of Serine5 phosphorylation (P-S5), a marker for initiated Pol II, are high, whereas phosphorylation levels at Serine2 (P-S2), a marker for the transition to productive elongation, are low (23, 24) . Hence, we examined CTD phosphorylation across the TNF␣ gene in resting and LPS-stimulated M⌽.
Consistent with polymerase stalling, Pol II adjacent to the TNF␣ TSS was phosphorylated on S5 in untreated BMM⌽ [supporting information (SI) Fig. S1A ], whereas P-S2 Pol II was undetectable ( Fig. 2A Left) . Upon LPS treatment, Pol II was strongly phosphorylated on S2 and associated with the downstream regions of TNF␣. Hence CTD phosphorylation at the TNF␣ gene suggested that Pol II initiated transcription in resting cells but required an additional signal (e.g., LPS-induced transcription factor binding) to undergo S2 phosphorylation, be released from the promoter, and enter productive elongation.
Indeed, cyclin T1, the regulatory subunit of the positive transcription elongation factor (P-TEFb) kinase complex responsible for S2 phosphorylation and release of stalled Pol II into the gene, was recruited to the TNF␣ proximal promoter specifically in response to LPS ( Fig. 2 A Right) . A modest LPS-induced increase in cyclin T1 occupancy was also seen downstream within the TNF␣ gene. ChIP analysis revealed a similar LPS-dependent increase in occupancy by Cdk9, the catalytic subunit of P-TEFb, at the TNF␣ promoter-proximal region (Fig. S1B) .
In stark contrast to TNF␣, a gene encoding an LPS-inducible chemokine IP-10 ( Fig. 2B Right) was devoid of detectible Pol II in resting BMM⌽; Pol II recruitment to the IP-10 promoter-proximal region and CTD phosphorylation on S5 and S2 were strictly LPS dependent ( Fig. 2B Right and Fig. S1 ). Consistent with the data at TNF␣ (Fig. 2 A) and previous studies (24) , levels of S2 phosphorylation were greater on the fully elongation-competent Pol II within the IP-10 gene than for the Pol II beginning productive elongation near the IP-10 promoter. Thus, IP-10 transcription appears to be controlled at the level of LPS-induced Pol II recruitment and preinitiation complex assembly. It has been previously shown that the 4-subunit NELF complex plays a key role in Pol II stalling by inhibiting early transcription elongation (25) (26) (27) . The negative effects of NELF are counteracted by phosphorylation of the CTD, and potentially NELF itself, by the P-TEFb kinase, whose recruitment is concomitant with release of stalled Pol II from the promoter region. To evaluate a possible role for NELF in regulating TNF␣ transcription in vivo, we first confirmed that NELF was expressed in M⌽ (Fig. S2) . Furthermore, immunohistochemical analysis revealed abundant NELF-E staining ( Fig. 3 B and E) in the nuclei of the resident M⌽ occupying the majority of the red pulp of the mouse spleen ( Fig. 3 A and D ; F4/80 staining); NELF-E expression appeared to be particularly high in M⌽ around and immediately adjacent to the white pulp of the follicles ( We next assessed NELF occupancy at several LPS target genes under basal and inducing conditions. Consistent with the idea that NELF inhibits early elongation, both NELF-E and NELF-A were present specifically in the promoter-proximal region of TNF␣ in resting RAW264.7 cells (Fig. 4A Right and Fig. S3A, respectively) . Similarly, NELF-A associated with the TNF␣ promoter in untreated BMM⌽ (Fig. 4B Right) . Interestingly, in both cell contexts, NELF occupancy rapidly and transiently decreased upon addition of LPS, which inversely correlated with TNF␣ RNA induction. These data suggested that gene activation involves the temporary dissociation of NELF from the TNF␣ promoter, allowing Pol II to efficiently elongate into the gene. Strikingly, by 1-2 h of LPS treatment, NELF resumed occupancy at the TNF␣ promoter (Fig. 4A and Fig. S3 ).
In contrast, we observed no appreciable NELF-A occupancy above the background of control IgG at the IP-10 gene (promoter proximally or downstream) in either resting or LPS-treated BMM⌽ whereas Pol II was, as expected, recruited in response to LPS (Fig. 4C ). In the same experiment NELF occupied the promoter of Eif4a1, a control gene whose transcription is LPS unresponsive, and importantly this occupancy was not altered in LPS-stimulated BMM⌽ (Fig. 4C ).
Permanganate Footprinting in BMM⌽ Reveals an Open Transcription
Bubble in the TNF␣ Promoter-Proximal Region. The above experiments suggested that Pol II recruited to the TNF␣ promoter in resting M⌽ initiated transcription but was halted within the promoter-proximal region by NELF. To confirm the presence of an engaged but stalled Pol II at TNF␣, we used in vivo permanganate footprinting, a technique that capitalizes on the ability of KMnO 4 to specifically interact with thymine bases in ssDNA, such as those in the open transcription bubble. When Pol II stalls near the promoter for an extended period, ss regions associated with an engaged Pol II can be readily detected by their KMnO 4 hyperreactivity. Fig. 5 (lane ''0'') illustrates strong permanganate reactivity in resting BMM⌽ from near the TNF␣ TSS through the promoter-proximal region (dashes). This finding is consistent with the presence of an open transcription bubble at the uninduced TNF␣ gene generated by Pol II, which has produced a short transcript and stalled during early transcription elongation. LPS treatment both enhanced (particularly at 0.5 h) and extended KMnO 4 reactivity further downstream into the gene (bracket), suggesting that Pol II has been released from the promoter to enter productive transcription elongation. This downstream expansion of the KMnO 4 -reactive region is reminiscent of the patterns seen at the induced heat-shock genes (28), as is the appearance of detectable reactivity at the TSS (asterisk), which indicates a very high level of transcription initiation upon gene activation.
Pol II Stalling at the Genes in the TNF Family Is Highly Evolutionarily
Conserved. Interestingly, recent studies identified eiger, the sole Drosophila member of the TNF family, as a gene whose expression was attenuated in NELF-depleted cells (19, 22) . Eiger, like TNF␣, is an essential, stress-inducible regulator of cell death pathways (29, 30) , critical for protection against extracellular pathogens. We therefore examined whether eiger is also regulated by Pol II stalling. Our ChIP analysis in Drosophila S2 cells revealed a striking resemblance of the Pol II and NELF-E binding profiles at eiger to those of Pol II and the NELF complex at the mammalian TNF␣ gene in M⌽. Indeed, both Pol II and NELF-E were strongly enriched at the eiger promoter-proximal region, but not in the upstream or downstream regions (Fig. 6A) . Furthermore, RNAi-mediated depletion of NELF significantly decreased Pol II occupancy at eiger (Fig. 6B) , consistent with the role of the NELF complex in maintaining stalled Pol II at this promoter. To obtain direct evidence for the transcriptional status of the Pol II bound near the eiger promoter, we performed permanganate footprinting of the gene. As shown in Fig. 6C , Pol II detected by ChIP is associated with a stalled, open transcription bubble in the eiger promoter-proximal region, as evidenced by KMnO 4 -sensitive sites at positions between ϩ34 and ϩ41 relative to the TSS. Further corroborating the idea that Pol II stalling at the eiger promoter is mediated by the NELF complex (Fig. 6B) , NELF-B knockdown by RNAi decreases KMnO 4 reactivity (Fig. 6C) . Combined, these data demonstrate a remarkable level of evolutionary conservation of the transcriptional regulatory mechanisms governing TNF gene expression from Drosophila to mammals.
Pol II Stalling and the RNA Induction Profile in LPS-Inducible Genes in
M⌽. In mammals, M⌽ represent an early line of defense against infection that respond to invading pathogens by producing a vast number of proinflammatory cytokines, chemokines, and factors that provide negative feedback loops limiting excessive inflammation. We quantified the expression of several such factors in LPS-treated M⌽ over time. As shown in Fig. 7 A and B , TNF␣ nascent unprocessed transcript, as measured by the amplification of the intronic region, was induced with strikingly rapid kinetics, reaching a maximum in both RAW264.7 cells and BMM⌽ by 0.5-1 h and dropping off precipitously thereafter. Interestingly, this down-regulation of TNF␣ transcription coincides with NELF reloading onto the gene (Fig. 4) . Consistent with earlier observations (11), the TTP gene displayed a fast and transient induction profile similar to that of TNF␣ itself (Fig. 7 A and B) . In contrast, IP-10 induction occurred much more gradually and was sustained for several hours; an even slower induction profile was characteristic of RANTES, another well-established LPS-inducible chemokine. Importantly, similarly ''delayed'' induction of IP-10 or RANTES was seen whether mRNA or nascent transcript was analyzed.
To begin to address the potential mechanisms underlying such dramatic differences in the transcriptional response of these 2 pairs of genes to a common stimulus, we assessed Pol II and NELF occupancy at TTP and RANTES. Pol II was significantly enriched at the TTP promoter-proximal region in untreated BMM⌽ (Fig.  7C) ; LPS treatment promoted additional Pol II loading onto the promoter and, particularly, the downstream region of the TTP gene. In addition, NELF complex occupied the TTP promoterproximal region in resting M⌽, was dismissed upon 0.5 h LPS exposure, coinciding with cycT1 recruitment, but resumed promoter occupancy by 1 h, as cycT1 occupancy began to decline (Fig.  7D ). These data were consistent with promoter-proximal Pol II stalling and LPS-dependent release and elongation at TTP, similar to that occurring at TNF␣. In contrast, RANTES was not occupied by Pol II or NELF in untreated BMM⌽ (Fig. 7 C and D) ; Pol II loading onto the RANTES promoter was LPS dependent, indicating that, as with IP-10, Pol II recruitment is a rate-limiting step in RANTES transcription. Thus, in a limited subset of genes tested, Pol II stalling correlated with a rapid and transient expression profile.
Pol II Stalling and Not the Nature of an Inducer Determines the Induction Profile of LPS Targets. Most cytokines and chemokines are induced by multiple PAMPs, which signal through specific TLRs. For example, bacterial lipopeptide Pam3Cys activates TLR2, dsRNA [and its synthetic analog poly(IC)] activates TLR3, and ssRNA signals through TLR7 (2). Signal transduction cascades initiated by these TLRs are partially overlapping yet distinct, creating a sophisticated regulatory matrix whereby, in principle, each PAMP may trigger a different transcriptional response of a given gene. We therefore examined the induction profile of TNF␣, TTP, IP-10, and RANTES in BMM⌽ treated with poly(IC), Pam3Cys, and ssRNA. We found that TNF␣ was induced by Pam3Cys and ssRNA and that TTP was highly ssRNA responsive, but, in all cases, their expression peaked by 0.5-1 h and subsided thereafter (Fig. 8A) . In contrast, activation of IP-10 by poly(IC) or RANTES by all 3 PAMPs did not peak until 3-5 h irrespective of the specific TLR engaged (Fig. 8B) . We conclude that for a given gene, the kinetics of induction are specific to the gene itself regardless of a signaling pathway responsible for activation and reflect a particular rate-limiting step in transcription (Pol II recruitment vs. release from promoter-proximal stalling).
Discussion
A key component of the innate immune system, myeloid cells including monocytes, macrophages, and dentritic cells respond to pathogens by mounting a surge of proinflammatory mediators.
Among the numerous factors that contribute to the local or systemic elevation of cytokine and chemokines levels, gene expression has been established as a fundamental mechanism that dictates their balance. Indeed, cytokine-encoding genes are rich in cis-acting elements for numerous transcriptional regulators. The combinatorial dynamics of many factors at a given gene are exemplified by the IFN␤ enhanceosome (31) , where transcription initiation requires the ordered assembly of the IRF, ATF/AP1, and NFB family members, followed by histone acetylation, nucleosome remodeling, and Pol II recruitment. Consequently, Pol II recruitment to a promoter has been traditionally considered the critical step in getting transcription underway. Yet, recent studies have begun to paint a very different picture of transcriptional regulation, whereby a sizable fraction of promoters are constitutively occupied by Pol II, and it is the polymerase release into productive elongation that is rate limiting. The notion that the rate-limiting step in transcription does not need to be Pol II recruitment is not in itself novel: Years ago, elegant studies from J. Lis's group demonstrated that the Drosophila heat-shock genes were regulated during early elongation (32) . A surprise, however, came from the recent genomewide studies in Drosophila revealing that up to 20% of genes may be controlled in a similar manner (19, 20) . Interestingly, many genes that harbor stalled Pol II encode inducible factors that respond to environmental or developmental triggers (19) . If this trend holds true in mammals, genes with promoter-proximally stalled Pol II may be enriched in the innate immune system, which specifically evolved to sense and respond efficiently to pathogens.
Here, we demonstrate that TNF␣, a broad spectrum inducer of inflammatory responses and a key molecule in the pathogenesis of many autoimmune and inflammatory diseases, is encoded by a stalled gene. Indeed, in resting cells, the TNF␣ promoter was co-occupied by NELF and S5-(but not S2-) phosphorylated Pol II that was engaged in early transcription elongation. LPS treatment triggered P-TEFb loading, a dramatic increase in S2 phosphorylation, a rapid yet transient dismissal of NELF from the promoter, and a release of Pol II into the gene.
Pol II stalling has been described for several mammalian immediate early genes including JunB, cFos, cMyc, and a number of estrogen receptor-regulated genes (33) (34) (35) . However, the regulated dissociation of NELF from the promoter region during gene induction, as shown for Drosophila heat-shock genes (36), has never before been reported in a mammalian system. Furthermore, the fact that Drosophila eiger is a NELF target gene, similarly controlled at the level of promoter proximal stalling, illustrates that the rate-limiting step in the transcription cycle for a given gene could be an ancient evolutionarily conserved mechanism of regulation.
On the basis of these data, we propose the following model for the role of Pol II stalling in the immune response: Before induction, Pol II and the transcription machinery are preloaded onto the promoters of many genes, but are held within the promoterproximal region by the NELF complex. This stalled elongation complex establishes a ''poised'' promoter structure, which may include (but is likely not limited to) the active histone marks recently found at such genes before induction (37) . Upon immune challenge, P-TEFb recruitment triggers the rapid transition of stalled Pol II to productive elongation and NELF release. During the early phase of induction, NELF binding and Pol II pausing within the promoterproximal region would be antagonized by the continued presence of high levels of P-TEFb. Over time, P-TEFb levels decline, allowing NELF to reassociate with Pol II and gene transcription to subside. Notably, the decline of the TNF␣ and TTP transcript levels is a compound of both a decrease in transcription levels and, as previously shown (14), RNA turnover. Future studies, including genetic disruption of mammalian NELF in the immune system, will address the functional role of this complex in transcriptional regulation of the stalled genes. The global role of Pol II stalling in the innate immune response is currently unknown. Conceivably, genes occupied by the stalled Pol II encode acutely inducible factors in the front line of host defenses, while those regulated via Pol II recruitment represent chemokines and mediators of tissue repair that are required later in the infectious process. It is tempting to speculate that the intrinsic danger imposed by potent proinflammatory cytokines such as TNF␣ also necessitates multiple mechanisms for a rapid shutoff, including the return of NELF to the promoter and arrest of elongation, prompt degradation of existing mRNA, and inactivation of the signaling pathway via negative feedback. Genomewide ChIP-chip or ChIP-seq approaches should reveal whether Pol II stalling indeed occurs preferentially in a specific functional group of immune mediators.
TNF␣ is a prototypic inflammatory cytokine whose critical role in the pathogenesis of several autoimmune diseases made it a prime therapeutic target in rheumatoid arthritis, psoriasis, inflammatory bowel disease, ankylosing spondylitis, and other disorders (38) . Given the extraordinary importance of this cytokine in human disease, much work has focused on dissecting the pathways responsible for its production. This study uncovered a fundamental, evolutionarily conserved mechanism that controls TNF␣ transcription in M⌽, which generate a bulk of TNF␣ during inflammatory processes. While many questions regarding the molecular determinants of Pol II stalling remain, this early elongation checkpoint may be subverted in disease, as suggested by recent data linking NELF dysregulation to enhanced cellular proliferation in breast cancer and gastrointestinal adenocarcinomas (39, 40) . Conceivably, altered NELF levels in M⌽ may lead to an exaggerated inflammatory response or autoimmunity. A possible correlation of an aberrant Pol II stalling profile with quantitatively or qualitatively different transcriptional response of TNF␣ would be of great interest to pursue in mouse models of systemic inflammation or autoimmune conditions.
Methods
Cell Culture and BMM⌽ Preparation. Mouse RAW264.7 cells were maintained in DMEM (Invitrogen) supplemented with 10% FBS (HyClone), treated with sterile PBS (vehicle) or LPS (1 g/mL) as described in the figure legends, and harvested. BMM⌽ were prepared from 8-wk-old C57BL/6 mice as described in ref. 41 except L-cell conditioned media were used for the 6-day M⌽ expansion; cells were then scraped, incubated in RPMI-20% FBS overnight, and treated as described in the figure legends.
Measurement of RNA Levels. Total RNA was isolated from RAW264.7 cells and BMM⌽ and analyzed (41) for the expression of each gene, using ␤-actin as an internal control. Primer pairs are listed in Table S1 .
Permanganate Footprinting. In vivo permanganate footprinting in Drosophila was performed as in ref. 19 . Day 7 BMM⌽ (Ϸ100 ϫ 10 6 ) were harvested in ice-cold PBS (400 ϫ g; 5 min), washed in PBS, collected as above, and subjected to KMnO 4 probing as in ref. 19 using 1 g DNA per reaction and 25 cycles of ligationmediated PCR (see primer sequences in Table S1 ).
ChIP Experiments and Immunohistochemistry. See SI Methods.
